Russell Investments Group Ltd. Has $37.91 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)

Russell Investments Group Ltd. grew its stake in shares of Cardinal Health, Inc. (NYSE:CAHGet Rating) by 70.5% in the third quarter, HoldingsChannel.com reports. The firm owned 567,121 shares of the company’s stock after purchasing an additional 234,444 shares during the period. Russell Investments Group Ltd.’s holdings in Cardinal Health were worth $37,906,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. LS Investment Advisors LLC bought a new position in shares of Cardinal Health during the 2nd quarter worth approximately $27,000. CX Institutional purchased a new stake in shares of Cardinal Health during the 2nd quarter valued at approximately $33,000. Retirement Group LLC boosted its holdings in Cardinal Health by 100.0% in the 2nd quarter. Retirement Group LLC now owns 862 shares of the company’s stock worth $45,000 after buying an additional 431 shares during the period. Massmutual Trust Co. FSB ADV grew its stake in Cardinal Health by 102.8% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 716 shares of the company’s stock valued at $48,000 after buying an additional 363 shares in the last quarter. Finally, FinTrust Capital Advisors LLC raised its holdings in Cardinal Health by 195.0% during the 2nd quarter. FinTrust Capital Advisors LLC now owns 885 shares of the company’s stock valued at $50,000 after acquiring an additional 585 shares during the period. Institutional investors own 88.93% of the company’s stock.

Cardinal Health Trading Down 0.8 %

Shares of CAH opened at $74.85 on Wednesday. The firm’s 50-day moving average price is $78.11 and its 200-day moving average price is $71.21. The firm has a market capitalization of $19.62 billion, a price-to-earnings ratio of 12.23, a PEG ratio of 1.22 and a beta of 0.81. Cardinal Health, Inc. has a 1-year low of $49.47 and a 1-year high of $81.57.

Cardinal Health (NYSE:CAHGet Rating) last released its quarterly earnings results on Friday, November 4th. The company reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.24. Cardinal Health had a negative return on equity of 252.82% and a negative net margin of 0.59%. The company had revenue of $49.60 billion for the quarter, compared to analyst estimates of $46.88 billion. On average, research analysts forecast that Cardinal Health, Inc. will post 5.3 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Sunday, January 15th. Stockholders of record on Tuesday, January 3rd were issued a dividend of $0.4957 per share. The ex-dividend date was Friday, December 30th. This represents a $1.98 annualized dividend and a dividend yield of 2.65%. Cardinal Health’s payout ratio is 32.35%.

Insider Buying and Selling

In other Cardinal Health news, insider Ola M. Snow sold 19,590 shares of the business’s stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $78.87, for a total transaction of $1,545,063.30. Following the completion of the sale, the insider now directly owns 31,187 shares in the company, valued at approximately $2,459,718.69. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.17% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CAH. Mizuho boosted their price objective on Cardinal Health from $66.00 to $74.00 and gave the company a “neutral” rating in a research note on Monday, November 14th. Morgan Stanley upped their target price on shares of Cardinal Health from $82.00 to $86.00 and gave the stock an “overweight” rating in a report on Friday, January 6th. Credit Suisse Group boosted their price target on shares of Cardinal Health from $64.00 to $79.00 and gave the company a “neutral” rating in a research report on Tuesday, November 22nd. Robert W. Baird raised their price target on Cardinal Health from $74.00 to $82.00 and gave the company a “neutral” rating in a report on Monday, November 7th. Finally, Bank of America upgraded shares of Cardinal Health from an “underperform” rating to a “neutral” rating and upped their price objective for the stock from $64.00 to $80.00 in a research report on Friday, November 4th. Eight equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Cardinal Health has a consensus rating of “Hold” and an average target price of $76.82.

About Cardinal Health

(Get Rating)

Cardinal Health, Inc is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency.

Read More

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHGet Rating).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.